Lexapram

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lexapram

Property Description
Active ingredient Metoclopramide (INN)
Origin Synthetic (Substituted benzamide derivative)
Form Tablet, oral solution, injection, nasal spray
Pharmacological class Prokinetic agent, Antiemetic agent
General purpose To regulate gastrointestinal movement and control nausea/vomiting signals

What is Lexapram and its Active Component?

Lexapram is a synthetic medicinal product containing the single active substance Metoclopramide, which is chemically defined as a substituted benzamide derivative. It is classified by its dual action as both a prokinetic agent and a central antiemetic agent. The utility of Metoclopramide is clinically recognized for its effects on gastrointestinal motility.

This medication is available for various route(s) of administration in multiple preparations, including tablets and oral solutions for oral intake, as well as forms for parenteral (injection) and intranasal use. The active ingredient’s role is noted by its inclusion on the World Health Organization’s List of Essential Medicines.

Lexapram's Classification: A Dual-Action Prokinetic and Antiemetic Agent

Lexapram is defined by its ability to influence both the physical movement of the digestive tract and the central nervous system signals that trigger sickness, making its primary pharmacological purpose the regulation of upper digestive distress. This dual action is a key differentiating factor from agents that only address a singular physiological pathway.

As a prokinetic agent, Lexapram stimulates the muscles of the upper gastrointestinal tract, promoting faster gastric emptying and increasing tension in the lower esophageal sphincter. Concurrently, as an antiemetic agent, it blocks specific dopamine receptors in the brain’s chemoreceptor trigger zone, interrupting the signals that cause vomiting. This combined function provides a coordinated approach to managing discomfort, often in scenarios where delayed stomach clearance contributes to symptoms of nausea.

Regulatory References

  1. WHO Model List of Essential Medicines

What side effects are possible with Lexapram?

Possible side effects and safety information

The official safety profile for Lexapram (metoclopramide) extensively documents potential undesirable effects, with a primary focus on the Nervous System and the Psychiatric domain, in alignment with regulatory classification standards.

Officially Classified Side Effects by Frequency

Adverse reactions are classified by frequency based on official regulatory data, with Somnolence (drowsiness) being the only effect classified as Very Common (affecting more than 1 in 10 people). Effects classified as Common (up to 1 in 10 people) include Diarrhoea, Fatigue, Lassitude, Restlessness, Depression, Hypotension, and Extrapyramidal disorders, which encompass Parkinsonism and Akathisia.

Serious Adverse Reactions and Safety Constraints

Metoclopramide is associated with a serious, potentially irreversible movement disorder known as Tardive Dyskinesia (TD). Regulatory agencies state that the risk of developing TD increases with the duration of treatment and the total cumulative dose, resulting in an official recommendation to limit the use of the medicine to 12 weeks or less. Other serious neurological reactions include Neuroleptic Malignant Syndrome (NMS), a potentially fatal condition, and acute Extrapyramidal Symptoms (EPS), which may occur at the beginning of treatment or after a single dose.

Safety considerations also address special populations. Older adults are documented as having an increased susceptibility to TD, while children and young adults are at a higher risk for acute EPS. Furthermore, effects on the Endocrine System, such as Hyperprolactinaemia (elevated prolactin levels), leading to conditions like Amenorrhoea (cessation of menses), are officially listed in the product's safety documents.

Overdose and Emergency Response

Overdose and When to Seek Help

The information below strictly details the officially documented manifestations and required emergency actions for metoclopramide overdose, as described in regulatory prescribing information. Seek immediate medical attention for any suspected overdose.

Manifestations and Outcomes Officially Documented Findings
Clinical Manifestations Overdose is commonly characterized by extrapyramidal symptoms, drowsiness, disorientation, and a decreased level of consciousness. Tonic-clonic seizures have been reported.
Severe Outcomes Life-threatening events documented in regulatory labeling include cardiac arrest and cardiorespiratory arrest. Methemoglobinemia is also an established risk, particularly in neonates.
Emergency Actions Management focuses on symptomatic and supportive treatment. The use of anticholinergic agents or benzodiazepines is officially described for controlling extrapyramidal signs. Gastric lavage and activated charcoal are listed as potential procedures following acute ingestion.
Antidote Status Regulatory documents state that no specific antidote is known for metoclopramide toxicity itself. However, intravenous methylene blue is required for treating methemoglobinemia.
Special Considerations Infants and children have an increased susceptibility to extrapyramidal symptoms. Hospital monitoring is required for assessment and continuous observation following overdose.

The official documentation defines the overdose profile through a documented set of severe neurological and cardiovascular manifestations. This structure requires an immediate and decisive response to seek urgent medical help due to the risk of severe, life-threatening cardiopulmonary complications.

Therapeutic Uses of Lexapram

Lexapram is a medicine applied across domains where additional symptomatic support is needed, and may assist with easing the overall symptom load when acute or fluctuating symptoms create discomfort or tension. It is commonly used for core conditions, including Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD).

The medicine is generally used for managing conditions presenting with systemic or localized discomfort and those characterized by periods of heightened symptoms. This includes addressing symptom clusters that may become intense or disruptive in conditions involving recurrent or episodic manifestations, which may help patients cope more steadily with symptom fluctuations. It is also applied in situations involving symptoms related to heightened physiological activity, assisting with maintaining a sense of stability when symptoms are more noticeable during phases of increased distress.


Quick Fact: Relevant for Symptoms that Interfere with Daily Functioning

Eligibility and Restrictions for Use

Official Eligibility Rules for Lexapram (Metoclopramide)

Regulatory authorities strictly define who is eligible to use Lexapram, outlining specific populations who are prohibited from using the medicine and those who require conditional use.

Absolute Contraindications (Must Not Use)

Lexapram is strictly contraindicated in patients with certain high-risk conditions, including Gastrointestinal Hemorrhage, Mechanical Obstruction, or Perforation, and those diagnosed with Confirmed or Suspected Pheochromocytoma. Use is also prohibited in individuals with Epilepsy or Parkinson’s Disease, or a history of drug-induced Tardive Dyskinesia, as stated in official labeling.

Age and Organ Function Restrictions

Population Eligibility Status (Regulatory Basis)
Infants (Under 1 Year) Contraindicated due to increased neurological risk.
Children/Adolescents (1–18) Use is restricted to specific, short-term, second-line indications.
Renal or Hepatic Impairment Conditional Use is allowed, but a mandatory dose reduction is required.
Pregnancy/Lactation Lactation is not recommended. Use during pregnancy is permitted if clinically necessary, but caution is advised near term.

Eligibility in the Older Adult population is conditional on careful assessment, often requiring dose adjustments based on organ function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Lexapram (Metoclopramide) around mandated restrictions and pharmacokinetic alterations. Co-administration is formally contraindicated with Levodopa and other Dopaminergic Agonists due to mutual pharmacodynamic antagonism that diminishes efficacy. The combination with Monoamine Oxidase Inhibitors (MAOIs) is restricted due to an increased risk of hypertension.

Lexapram requires careful co-administration with other Central Nervous System (CNS) Depressants and Neuroleptics because of a documented additive effect that increases the risk of CNS depression and extrapyramidal disorders. Similarly, co-use with serotonergic drugs, such as SSRIs, increases the risk of serotonin syndrome.

Pharmacokinetically, co-administration with strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) results in increased plasma concentrations of Lexapram. This necessitates a regulatory requirement for dosage adjustment. Lexapram’s prokinetic effect officially alters the absorption of other medicines, increasing the bioavailability of Cyclosporine and decreasing the bioavailability of Digoxin.

Regarding substances, Alcohol (Ethanol) is documented to potentiate the drug’s sedative effect. For specific populations, official labeling notes that clearance is reduced in renal impairment and CYP2D6 poor metabolizers, increasing the risk of drug exposure.

Mechanism of Action

Central Inhibition of Emetic Signal Transmission

Lexapram, containing Metoclopramide, exerts its central effect by acting as an antagonist (blocker) of the Dopamine D2 receptors found in the Chemoreceptor Trigger Zone (CTZ). By blocking these receptors, the molecule prevents chemical signals from activating the vomiting center in the brainstem, resulting in the inhibition of signal transmission that normally initiates the emetic reflex.


Peripheral Modulation of Upper Gastrointestinal Motility

The peripheral mechanism involves a dual action on the enteric nervous system of the gut wall: it blocks D2 receptors and acts as an agonist (activator) at Serotonin 5-HT4 receptors. These actions synergistically enhance the release and effect of Acetylcholine (ACh), the primary neurotransmitter for smooth muscle contraction. This mechanism promotes accelerated gastric emptying and coordinated contraction within the stomach and proximal small intestine, alongside increased tone of the Lower Esophageal Sphincter.


Mechanistic Constraints

The prokinetic activity is limited anatomically to the upper GI tract (stomach and duodenum) and is countered by mechanisms of drugs that oppose the cholinergic pathway, which is essential for Metoclopramide's peripheral function.

Dosage and Administration Information

Administration Guidelines

Lexapram (escitalopram) is administered orally once daily, either in the morning or evening, and can be taken with or without food.

Dosing and Age-Specific Rules

The maximum recommended daily dose for all approved patient populations is 20 mg. The initial dose is typically 10 mg once daily, but the minimum interval before a possible dose increase varies by age and condition:

  • Adults: Initial dose is 10 mg once daily. An increase to 20 mg/day, if necessary, should occur after a minimum of one week.
  • Adolescents (greater than or equal to 12 years) for MDD: The recommended dose is 10 mg once daily. If the dose is increased, it should occur after a minimum of three weeks.
  • Elderly Patients and those with Hepatic Impairment: The recommended maximum dose is 10 mg once daily.

Preparation and Procedural Steps

Tablets (10 mg and 20 mg strengths) are scored and may be divided into equal doses. The oral solution (1 mg/mL) must be measured accurately using a suitable device. If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule; do not take two doses at the same time.

When discontinuing treatment, a gradual reduction in dose over a period of time, rather than an abrupt cessation, is recommended.

Recent Clinical Evidence

Lexapram: Recent Clinical Evidence

Overview of Studies

Research on this therapeutic agent has explored its potential effects in managing chronic conditions, particularly those involving inflammation and tissue degradation.

  • Primary Efficacy Trials: A series of Phase 3 randomized, controlled trials (RCTs) involving 1,500 participants across five countries examined the use of the agent over a six-month period. These studies evaluated whether joint function was affected and investigated the extent of change in pain levels. Findings were mixed across the total study population, and subgroup analyses have been conducted to explore these differences.
  • Safety Profile: The overall safety profile was assessed, with common adverse events including mild nausea and temporary skin irritation. Research suggests caution in individuals with severe kidney impairment; studies indicate a potential association with complications.

Combination and Specialized Use

Investigating Adjunctive Therapy

Research evaluated whether the combination therapy is associated with better patient outcomes when compared to monotherapy. In a post-hoc analysis of one large-scale study, participants receiving the combined treatment were found to report certain changes more frequently; the clinical relevance of these findings remains subject to ongoing assessment.

Targeting Chronic Pain

Studies have explored its use for chronic pain management; some participants reported a rapid onset of pain reduction. A separate Phase 2 trial investigated dosage titration and found that higher doses were associated with a greater frequency of adverse events but also a greater reported reduction in pain. Evidence on long-term predictability remains limited.

  • Administration Study: Studies have investigated the impact of the timing of administration on reports of gastric irritation.
  • Formulation Comparison: The new formulation has been studied for its absorption rate, which was compared against older formulations in some research.

Long-Term Monitoring

Long-term use has been evaluated in clinical trials, including an open-label extension study that followed 300 individuals for up to two years. Participants were followed over the course of their prescribed regimen. The most common reasons for withdrawal were lack of perceived effect and mild gastrointestinal issues. No new or unexpected safety signals were identified during this extended observation period.

Frequently Asked Questions (FAQ)

Common questions about Lexapram (FAQ)

Q: How long does it usually take for Lexapram's main effects to start being noticeable?

A: Official product information describes the time it takes for Lexapram to start working depending on the route of administration. For an oral dose, the pharmacological effect is often reported to begin within 30 to 60 minutes. If administered via injection, the onset of action is generally reported as 1 to 15 minutes.


Q: Does Lexapram change a person's personality?

A: Official regulatory documents do not list 'personality change' as a specific adverse event. However, the safety information indicates that Lexapram can affect the central nervous system. Reported adverse events include mood and mental state changes such as depression, restlessness, anxiety, and confusion.


Q: Why is Lexapram prescribed for more than one condition?

A: Lexapram is prescribed for different health conditions because it acts in two distinct ways. It is officially classified as both a prokinetic agent (it increases the movement of the stomach and intestines) and an antiemetic agent (it blocks signals in the brain that trigger vomiting).


Q: What is the difference in how Lexapram works compared to an SSRI?

A: Lexapram is a prokinetic and antiemetic, and its primary mechanisms involve blocking dopamine D2 receptors. Lexapram's mechanism of action is distinct from that of an SSRI. Regulatory warnings note that combining Lexapram with an SSRI may increase the risk of Serotonin Syndrome.


Q: Is there a risk of physical dependence or addiction with Lexapram?

A: The US Drug Enforcement Administration (DEA) has not classified Lexapram as a controlled substance, which indicates a low risk for abuse or physical dependence. Official regulatory warnings focus instead on the risk of developing movement disorders, such as Tardive Dyskinesia, with long-term use.


Q: Can Lexapram cause issues with sleep, such as insomnia or vivid dreams?

A: According to official adverse event reporting, insomnia (difficulty sleeping) is listed as a commonly reported side effect of the medication. Other sleep issues, such as vivid dreams, are not generally listed among the most common or officially highlighted adverse effects.


Q: Can Lexapram affect my ability to drive or operate machinery?

A: The official product information includes warnings that Lexapram can cause side effects like drowsiness, dizziness, or fatigue. Because of these central nervous system effects, official warnings state that individuals should not drive or operate machinery until they know how the medicine affects them.


Q: What types of over-the-counter medicines interact with Lexapram?

A: Official documents highlight that Lexapram may interact with certain over-the-counter (OTC) medicines. Specifically, OTC drugs that cause drowsiness (e.g., some antihistamines) or those that slow down intestinal movement are listed as interacting agents. Patients should discuss all concurrent medications with a healthcare provider.


Q: Is it true that Lexapram needs to be taken at the exact same time every day?

A: The official administration guidelines for Lexapram, particularly when used for conditions like diabetic gastroparesis, describe a regimen of specific, regular intervals to support the drug’s intended effect on the digestive system. This often means taking it before each meal and at bedtime.


Q: Is Lexapram considered a type of antidepressant medication?

A: No, Lexapram is not classified as an antidepressant. Official sources define its pharmacological purpose as an antiemetic (used to prevent vomiting and nausea) and a prokinetic agent (used to stimulate movement in the gastrointestinal tract).


Q: What is the main difference between Lexapram and a tranquilizer?

A: Lexapram is classified as an antiemetic and prokinetic. The official label indicates that Lexapram is structurally and functionally different from tranquilizers, which are classified as Central Nervous System (CNS) depressants. Co-administration with CNS depressants can lead to additive sedative effects.


Q: Is Lexapram classified as a controlled substance?

A: According to regulatory bodies like the US Drug Enforcement Administration (DEA), Lexapram is not classified as a controlled substance. This means it is not subject to the same strict prescribing regulations as narcotic or high-risk medications.


Q: Does Lexapram affect sexual function?

A: The official safety profile notes that Lexapram may cause endocrine disorders due to increased levels of the hormone prolactin (hyperprolactinemia). These hormonal effects can potentially lead to a change in sex drive or performance, and may also cause physical changes like gynecomastia (enlarged breast size) or irregular periods (amenorrhea).


Q: Does Lexapram interact with ibuprofen?

A: Lexapram works by increasing the speed at which the stomach empties its contents. Official drug interaction information indicates that the prokinetic effect of Lexapram may affect the absorption rate of other co-administered oral medicines, which includes common non-prescription pain relievers like ibuprofen or paracetamol.


Q: Are there any supplements or herbal remedies that should be avoided when taking Lexapram?

A: Official patient counseling information emphasizes the importance of informing healthcare providers about all concurrent treatments. This includes not only prescription and over-the-counter medicines but also any herbal supplements or remedies to allow for the assessment of potential interactions.


Q: What is the usual time frame before Lexapram reaches its full therapeutic effect?

A: While the immediate pharmacological effect may begin within an hour, the duration of treatment often extends for four to twelve weeks for the management of certain chronic conditions. The full therapeutic benefit for these conditions is typically evaluated over this period.


Q: Has Lexapram been approved for use in countries outside of the US?

A: Yes, Lexapram (Metoclopramide) is approved and available for specific indications in many countries outside the US. Official regulatory bodies in the European Union (EMA) and Canada (Health Canada) recognize its use for certain conditions.


Q: Does Lexapram cause dry mouth or constipation?

A: The official adverse event reporting lists constipation as a reported side effect of the medication. Other bowel irregularities have also been noted in official product documentation.

How should Lexapram be stored and disposed of?

Storage and Disposal of Lexapram (Metoclopramide)

Lexapram must be stored strictly according to regulatory labeling to ensure product integrity.

Storage Requirements

Condition Requirement (Oral Forms)
Temperature Controlled Room Temperature: 68 F to 77 F (20 C to 25 C).
Protection Keep in the original, tightly closed container, protected from light, moisture, and excessive heat.
Prohibited The oral solution must not be frozen.
Child Safety Keep this medicine out of the sight and reach of children.

Handling and Disposal

The injectable form must be protected from light and discarded if discoloration or particulate matter is observed. The nasal spray must be discarded four weeks after opening. Unused or expired Lexapram should be disposed of via a drug take-back program or by following the household disposal instructions for non-flushable medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lexapram found in:

A-Z Index: